The company shares that it will be launching Evolutha – a medical device class 3 with fragmented hyaluronic acid (HA), choline and amino acids to stimulating collagen and create a lifting effect. Caromed will also be debuting Reversha – a regenerative booster with exosomes, polynucleotides, HA, peptides and vitamins – and LongevHA, which incorporates highly concentrated HA in two molecular weights.
Max Candini, chief of global business development, said, “We are thrilled to launch LongevHA in the UK – the first SIRT1 (longevity gene) booster – along with two other formulations in our regenerative range, setting a new standard in skin revitalisation.”
